Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide
Healthcare News
- 401 Columbus Ave, Valhalla,
NY 10595, United States - Mon to Fri : 8:30 am – 4:30 pm
Sat & Sun : Holiday